Literature DB >> 22919111

Should there be a cap on the number of patients under the care of a clinical pharmacist?

.   

Abstract

Entities:  

Year:  2012        PMID： 22919111      PMCID： PMC3420856          DOI： 10.4212/cjhp.v65i4.1164

Source DB:  PubMed          Journal:  Can J Hosp Pharm        ISSN： 0008-4123


× No keyword cloud information.
  14 in total

1.  Staffing and the cost of clinical and hospital pharmacy services in United States hospitals.

Authors:  C A Bond; C L Raehl; M E Pitterle
Journal:  Pharmacotherapy       Date:  1999-06       Impact factor: 4.705

2.  Should Pharmacy Technicians Provide Clinical Services or Perform Patient Care Activities in Areas without a Pharmacist?

Authors: 
Journal:  Can J Hosp Pharm       Date:  2010-09

3.  Clinical pharmacy services, pharmacy staffing, and hospital mortality rates.

Authors:  C A Bond; Cynthia L Raehl
Journal:  Pharmacotherapy       Date:  2007-04       Impact factor: 4.705

4.  Cost implications of and potential adverse events prevented by interventions of a critical care pharmacist.

Authors:  Brian J Kopp; Melinda Mrsan; Brian L Erstad; Jeremiah J Duby
Journal:  Am J Health Syst Pharm       Date:  2007-12-01       Impact factor: 2.637

Review 5.  ACCP: economic evaluations of clinical pharmacy services: 2001-2005.

Authors:  Alexandra Perez; Fred Doloresco; James M Hoffman; Patrick D Meek; Daniel R Touchette; Lee C Vermeulen; Glen T Schumock
Journal:  Pharmacotherapy       Date:  2009-01       Impact factor: 4.705

Review 6.  Clinical pharmacists and inpatient medical care: a systematic review.

Authors:  Peter J Kaboli; Angela B Hoth; Brad J McClimon; Jeffrey L Schnipper
Journal:  Arch Intern Med       Date:  2006-05-08

7.  A prospective, randomized trial to assess the cost impact of pharmacist-initiated interventions.

Authors:  S T McMullin; J A Hennenfent; D J Ritchie; W Y Huey; T P Lonergan; R A Schaiff; M E Tonn; T C Bailey
Journal:  Arch Intern Med       Date:  1999-10-25

8.  Clinical pharmacy services, pharmacy staffing, and adverse drug reactions in United States hospitals.

Authors:  C A Bond; Cynthia L Raehl
Journal:  Pharmacotherapy       Date:  2006-06       Impact factor: 4.705

9.  Clinical and economic outcomes of involving pharmacists in the direct care of critically ill patients with infections.

Authors:  Robert MacLaren; C A Bond; Steven J Martin; David Fike
Journal:  Crit Care Med       Date:  2008-12       Impact factor: 7.598

10.  Capturing outcomes of clinical activities performed by a rounding pharmacist practicing in a team environment: the COLLABORATE study [NCT00351676].

Authors:  Mark J Makowsky; Sheri L Koshman; William K Midodzi; Ross T Tsuyuki
Journal:  Med Care       Date:  2009-06       Impact factor: 2.983
View more
  2 in total

1.  The Impact of Pharmacy-specific Predictors on the Performance of 30-Day Readmission Risk Prediction Models.

Authors:  Samuel Kabue; John Greene; Patricia Kipnis; Brian Lawson; Gina Rinetti-Vargas; Vincent Liu; Gabriel Escobar
Journal:  Med Care       Date:  2019-04       Impact factor: 2.983

2.  Barriers to and Enablers of Implementation of High-Value Interventions by Renal Pharmacists: A Qualitative Study Informed by the Theoretical Domains Framework.

Authors:  William Nevers; Alice Ratcheva; Kate Boutin; Sean K Gorman; Richard Slavik; Natalie Lesko
Journal:  Can J Hosp Pharm       Date:  2020-06-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.